Howe Jill Ann

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$18,195.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Howe Jill Ann

According to the SEC Form 4 filings, Howe Jill Ann, being in a position of

  1. Chief Financial Officer at Lineage Cell Therapeutics, Inc.,
    оver the last 12 months, has bought 25500 shares for $18,195, and sold 0 shares,
    over all time since 2024-08-16, has bought 25500 shares for $18,195, and sold 0 shares.

The largest purchase of all time was on 2024-08-16 and amounted to 10500 shares of Lineage Cell Therapeutics, Inc. for $9,345.

Biography of Howe Jill Ann

No biography is available at this moment.

2024-11-26PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
15,000
0.0082%
$0.59$8,850-5.98%
2024-08-16PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
10,500
0.0059%
$0.89$9,3450%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.